BIOINTAXIS
Spinout from the Igtp for neurodegenerative rare diseases.
BIOINTAXIS
Social Links:
Industry:
Health Care
Founded:
2019-07-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.biointaxis.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
880 K EUR
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Spamtador
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
Spinogenix
Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.biointaxis.com Semrush global rank: 9.78 M Semrush visits lastest month: 109
- Host name: advanced02.internovatec.com
- IP address: 46.231.5.48
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "Biointaxis"
Changing the paradigm in Friedreich´s ataxia
Biointaxis creates significant value at the early stages of product development (R&D), Pre-clinical (proof-of-concept and regulatory) and early clinical trials (Phase I/II). We aim to license the production and distribution rights to Pharma …See details»
Biointaxis - Crunchbase Company Profile & Funding
Organization. Biointaxis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Biointaxis is a genomic treatment and …See details»
Biointaxis Company Profile 2024: Valuation, Funding
Biointaxis General Information Description. Developer of genomic treatments designed for neurological diseases. The company develops innovative gene therapy to re-establish the function of a defective protein, enabling patients …See details»
BIOINTAXIS - LinkedIn
Biointaxis is an academic spin-off focused on the development of gene therapies for neurodegenerative disorders. Biointaxis lead product is a gene therapy product for Friedreich ataxia.See details»
BIOINTAXIS S.L. at Barcelona & Catalonia Startup Hub
Biointaxis s.l.a biotechnology company created in 2018, focuses its activity on scientific and technical research that leads to the discovery and development of therapeutic products …See details»
News | IGTP - germanstrias.org
Biointaxis, the new spin-off company of the IGTP, was recently constituted. The company stems from research led by Dr Antoni Matilla-Dueñas together with Dr Ivelisse Sánchez of the …See details»
Biointaxis - Funding, Financials, Valuation & Investors - Crunchbase
Biointaxis is a biotechnology company that develops and offers advance technology products for neurodegenerative diseases. Search Crunchbase. Start Free Trial . ... How much funding has …See details»
La startup biotecnológica Biointaxis capta 2,17 millones del …
Oct 23, 2024 La startup biotecnológica Biointaxis capta 2,17 millones del Ministerio de Ciencia y la Comisión Europea La compañía busca impulsar su terapia génica contra la ataxia de …See details»
GENE THERAPY Biointaxis FOR THE KNOWLEDGE - bcu.cat
Of Biointaxis, started to investigate the origin of ataxias and their genetic causes. In 2014, he made a step towards finding a cure for Friederich’s ataxia, the most common kind, with around …See details»
Ivelisse Sanchez, Ph.D. - co-Founder and Chief Scientific ... - The Org
In 2018, Dr. Sanchez became the co-Founder and Chief Scientific Officer of Biointaxis, an academic spin-off focused on the development of a gene therapy for rare neurodegenerative …See details»
Biointaxis - VentureRadar
" Biointaxis is an academic spin-off company benefiting from extensive know-how in the identification of genes and mechanisms underlying neurodegenerative disorders. Our the …See details»
Biointaxis - Crunchbase
Biointaxis is a biotechnology company that develops and offers advance technology products for neurodegenerative diseases.See details»
BIOINTAXIS - A NEW COMPANY DEDICATED TO THE …
Mar 13, 2019 Originally a foundation at the Institut d’Investigació en Ciències de la salut Germans Trias i Pujol (IGTP), Biointaxis has been created for the investigation of rare …See details»
News - IGTP
Dec 3, 2021 952,000 euros for the IGTP Spin-Off Biointaxis to develop gene therapy for Friedriech’s ataxia. Friday, 3 December 2021. Biointaxis, spin-off company from the Germans …See details»
'Get to Know' - Biointaxis - YouTube
Biointaxis, a spin-off of the Germans Trias i Pujol Research Institute (IGTP), is dedicated to scientific and technical research aimed at developing and comm...See details»
News - IGTP
Biointaxis, a spin-off of the IGTP, has the main objective of developing of a unique treatment to cure Friedreich's Ataxia. Friedreich's ataxia is a hereditary (genetic) progressive …See details»
Biointaxis - Contacts, Employees, Board Members, Advisors
Organization. Biointaxis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. Biointaxis has 2 …See details»
Ruta de navegación - CDTI
May 31, 2024 La innovadora terapia curativa de Biointaxis consiste en suministrar frataxina a las células del sistema nervioso, y otros tejidos críticos como el corazón, con el objetivo de …See details»
De la ciencia al mercado: terapia génica contra la ataxia
Jul 24, 2021 Biointaxis ha puesto en marcha este verano una ronda de financiación por el sistema de equity crowdfunding a través de la plataforma Capital Cell para captar 880.000 …See details»
Biointaxis - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 Organization. Biointaxis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 6. Monthly …See details»